Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ilinca D. Metes"'
Autor:
Ilinca D. Metes, Lingshu Xue, Chung-Chou H. Chang, Haiden A. Huskamp, Walid F. Gellad, Wei-Hsuan Lo-Ciganic, Niteesh K. Choudhry, Seth Richards-Shubik, Hasan Guclu, Julie M. Donohue
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background In the United States, there is well-documented regional variation in prescription drug spending. However, the specific role of physician adoption of brand name drugs on the variation in patient-level prescription drug spending is
Externí odkaz:
https://doaj.org/article/1d4fc6cf3f014402a225dc994ff169aa
Autor:
Judy C. Chang, Mark S. Roberts, Marc C. Levesque, Yomei Shaw, Julie M. Donohue, Ilinca D. Metes, Kaleb Michaud
Publikováno v:
Arthritis Care & Research. 70:533-541
Objective: Patient refusal of and nonadherence to treatment with disease-modifying antirheumatic drugs (DMARDs) can adversely affect disease outcomes in rheumatoid arthritis (RA). This qualitative study describes how RA patients' feelings in response
Autor:
Natasha, Parekh, Sheryl, Savage, Amy, Helwig, Patrick, Alger, Ilinca D, Metes, Sandra, McAnallen, William H, Shrank
Publikováno v:
The American journal of managed care. 25(7)
Physician satisfaction is associated with patient satisfaction, adherence to treatment recommendations, and quality. However, burnout is prevalent, and physician experience with health plans is likely a key contributor. We explored physician satisfac
Autor:
Julie M. Donohue, Niteesh K. Choudhry, Hasan Guclu, Seth Richards-Shubik, Haiden A. Huskamp, Chung-Chou H. Chang, Ilinca D. Metes, Wei-Hsuan Lo-Ciganic, Walid F. Gellad, Lingshu Xue
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Health Services Research, Vol 19, Iss 1, Pp 1-11 (2019)
Background In the United States, there is well-documented regional variation in prescription drug spending. However, the specific role of physician adoption of brand name drugs on the variation in patient-level prescription drug spending is still bei
Autor:
Chad Stephens, Marc C. Levesque, Diane Koontz, Ilinca D. Metes, Danielle Goudeau, Chester V. Oddis, Noreen Fertig, Rohit Aggarwal, Zengbiao Qi
Publikováno v:
Rheumatology. 54:1194-1199
Objective. The aim of this study was to develop and validate a quantitative anti-signal recognition particle (SRP) autoantibody serum ELISA in patients with myositis and longitudinal association with myositis disease activity. Methods. We developed a
Autor:
Marc C. Levesque, Ilinca D. Metes, S. Louis Bridges, Goundappa K. Balasubramani, Larry W. Moreland, Yong Gil Hwang
Publikováno v:
Arthritis Research & Therapy
Background The aim was to compare the effect of etanercept (ETN) and conventional synthetic disease-modifying anti-rheumatic drug (DMARD) therapy on serum amyloid A (SAA) levels and to determine whether SAA reflects rheumatoid arthritis (RA) disease
Autor:
Diane Koontz, Noreen Fertig, Ilinca D. Metes, Marc C. Levesque, Rohit Aggarwal, Zengbiao Qi, Chad Stephens, Danielle Goudeau, Chester V. Oddis
Objectives. A quantitative anti-transcription intermediary factor 1-gamma (anti-TIF1-γ) ELISA may improve the detection of cancer-associated myositis (CAM). The aims of this study were the development and validation of a quantitative anti-TIF1-γ au
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::753f3f13d781010cf2b0aeaa424d9cce
https://europepmc.org/articles/PMC3930887/
https://europepmc.org/articles/PMC3930887/
Autor:
M. S. Roberts, Heather Eng, Marc C. Levesque, Yomei Shaw, Chung-Chou H. Chang, Larry W. Moreland, S. R. Wisniewski, Ilinca D. Metes
Publikováno v:
Annals of the Rheumatic Diseases. 72:A53.2-A53
Background The European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) recommend that rheumatoid arthritis (RA) patients should be treated to the target of low disease activity or remission with traditional and biolo